Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-22-049960

Director sold 21,267 shares at $3.61 ($76,774)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
EASTHAM KARIN Director 2022-09-13 Sale −21,267 $3.61 $76,774 13,033 D
Open-market sales · 21,267 sh · avg $3.61 · $76,774
Loading xslF345X03/doc4.xml…